Bionaut Labs Closes $43M in Series B Led by Khosla Ventures to Advance First-in-Class Micro-Robotic Technology and Remove Barriers to Treat Rare and Debilitating Diseases
Bionaut™ treatment platform deploys remote-controlled microscale robots capable of delivering therapies locally to inaccessible disease

